Sunshine Holdings Plc · CSELK:SUN.N0000
Sunshine — Q1 FY2027 Earnings Presentation
39 slides from Sunshine's earnings presentation, Aug 10, 2026
Slide 1: 1QFY27 Earnings Webinar
1QFY27 Earnings Webinar Sunshine Holdings PLC 10 August 2026
Slide 2: Housekeeping Announcements
Housekeeping Announcements • The webinar will be recorded and later uploaded to our IR website as well as CSE website for future reference (https://www.sunshineholdings.lk/investor-relations/) • All participants will be muted during the presentation • Participants can use the 'Raise Hand' option to
Slide 3: Team
Team Shyam Sathasivam Aruna Deepthikumara Eranga Illangasinghe Shafras Anver Group CEO Group CFO Sector Financial Controller Sector Financial Controller SUNSHINE HOLDINGS SUNSHINE HOLDINGS SUNSHINE HEALTHCARE SUNSHINE CONSUMER
Slide 4: Corporate Announcements
Corporate Announcements • 26th June 2026 – Sunshine Healthcare Lanka Limited (a subsidiary of Sunshine Holdings PLC) entered into a 50:50 joint venture with India's Zydus Lifesciences Limited to establish Zydus Sunshine Lifesciences (Private) Limited, which will develop and operate a GMP-compliant o
Slide 5: Group Performance
Group Performance
Slide 6: Group at a glance – 1QFY27
Group at a glance – 1QFY27 Revenue Composition – 1QFY27 LKR 2.4bn LKR 1.4bn LKR 0.34 Agriculture -7.7% YoY +6.0% YoY -1.4% YoY 12.7% EBIT Earnings EPS 15.2% LKR 18.5bn 31.1% 15.5% LKR 9.87 49.2% +10.4 pts YoY -0.6 pts YoY -1.9% YoY Gearing ROE NBV 16.6% Healthcare 35.6% 5.9% Consumer 38.0% LKR 61.2b
Slide 7: Group – Performance Highlights
Group – Performance Highlights 1QFY27 1QFY26* YoY% 4QFY26* QoQ % Revenue 18,538 15,893 16.6% 17,068 8.6% EBIT 2,440 2,645 -7.7% 1,806 35.1% EBIT margin 13.2% 16.6% 10.6% PAT 1,407 1,327 6.0% 765 84.0% PAT margin 7.6% 8.4% 4.5% PATMI 665 675 -1.4% 496 34.2% EPS (LKR) 0.34 0.34 -1.4% 0.25 34.2% • Driv
Slide 8: Movement in Revenue & EBIT
Movement in Revenue & EBIT Revenue Movement [LKR Million] EBIT Movement [LKR Million] 1,816 317 1 18,538 2,645 509 110 18 2,440 15,893 89 (421) 1QFY26 Healthcare Consumer Agri Other 1QFY27 1QFY26 Healthcare Consumer Agri Other 1QFY27 Revenue Composition – Revenue QoQ 20.0 18.0 15% 16.0 13% 13% 14% 1
Slide 9: Healthcare
Healthcare
Slide 10: Sunshine Healthcare Lanka: fully integrated healthcare company
Sunshine Healthcare Lanka is Sri Lanka’s only fully integrated healthcare company encompassing the entire pharma value chain Government and Local market Manufacturing and R&D Revenue Split 1QFY27 Pharma Manufacturing, Sri Lanka’s first facility for Respiratory Care 12% Capsules Tablets Nasal Spray D
Slide 11: Healthcare Sector – Highlights
Healthcare Sector – Highlights Sector Highlights 9,756 10,348 8,619 8,714 9,129 Healthcare sector revenue grew 5.9% YoY in 1QFY27, driven by sustained momentum across the medical devices and pharmaceutical manufacturing businesses. However, the sector’s overall profitability continued to be 1,210 im
Slide 12: Sunshine Pharmaceuticals – Performance Highlights
Sunshine Pharmaceuticals – Performance Highlights Business Highlights 8,877 The pharmaceutical segment’s revenue declined by 18.2% YoY in 1QFY27, primarily due to price reductions, coupled with supply-side 5,137 challenges. 4,730 4,202 3,758 During Jan – Mar quarter, the market had value growth of 9
Slide 13: Healthguard Distribution – Performance Highlights
Healthguard Distribution – Performance Highlights Business Highlights 6,549 The Distribution segment’s revenue reported marginal degrowth of 0.3% YoY in 1QFY27, driven by a volume degrowth of 1.1%. 5,969 The decline in 1QFY27 was primarily due to lower volumes and 5,869 5,894 5,852 industry-wide con
Slide 14: Sunshine Medical Devices – Performance Highlights
Sunshine Medical Devices – Performance Highlights Business Highlights 1,453 1,464 The Medical Devices segment recorded an 8.8% YoY revenue 1,360 growth in 1QFY27 reflecting improved performance in both private and government segments during the quarter. 1,251 1,237 1QFY26 2QFY26 3QFY26 4QFY26 1QFY27
Slide 15: Lina Manufacturing – Performance Highlights
Lina Manufacturing – Performance Highlights Business Highlights 1,174 1,093 During 1QFY27, revenue from the manufacturing business recorded 906 931 895 a robust growth of 20.5% YoY, primarily driven by government product deliveries in line with the calendar year 2026 requirements. 1QFY26 2QFY26 3QFY
Slide 16: Healthguard Pharmacy – Performance Highlights
Healthguard Pharmacy – Performance Highlights Business Highlights 762 756 752 The Retail segment, Healthguard Pharmacy, recorded a 0.9% YoY degrowth in 1QFY27, driven by volume and value degrowth across both pharmaceutical and wellness ranges. 735 729 1QFY26 2QFY26 3QFY26 4QFY26 1QFY27 Revenue (LKR
Slide 17: Consumer Sector
Consumer Sector
Slide 18: Sunshine Consumer, market leader in branded tea, confectionery and cinnamon
Sunshine Consumer, market leader in branded tea, confectionery and organic Ceylon cinnamon exports Tea Brand Portfolio Revenue Split 1QFY27 Largest branded tea company in Sri Lanka – 49.4% General Trade Inter Co. / market share. *Pepper Cube May 2026 I Shares are 3 months average for end period Othe
Slide 19: Consumer Sector – Highlights
Consumer Sector – Highlights Sector Highlights 6,597 4,983 4,781 4,732 4,542 The Consumer sector, which includes tea and confectionery brands and export of tea and spices, recorded a revenue of LKR 6.6 Bn, an improvement of 38.0% YoY in 1QFY27. The growth was mainly due to the consolidation of JAPC,
Slide 20: Tea Brands – Performance Highlights
Tea Brands – Performance Highlights Business Highlights 2,725 2,631 2,650 Revenue from the Branded Tea business grew by 8.3% YoY to LKR 2.4 Bn in 1QFY27, driven by strong execution in modern trade and 2,464 retail channels with focused promotions. 2,276 Watawala Thei remained the key volume contribu
Slide 21: Confectionery Brands – Performance Highlights
Confectionery Brands – Performance Highlights Business Highlights 565 557 Revenue from the Confectionery business improved by 6.9% YoY in 529 530 1QFY27, driven by strong growth in the Gums category, alongside focused distribution expansion and promotional initiatives across the business. 476 1QFY26
Slide 22: Tea Exports – Performance Highlights
Tea Exports – Performance Highlights Business Highlights 2,066 USD 5.7 Mn 1,936 1,850 The export business recorded a revenue contraction of 6.3% YoY in 1,628 1QFY27 to reach LKR 1.9 Bn, mainly due to reduced volumes from 1,452 key clients. 1QFY26 2QFY26 3QFY26 4QFY26 1QFY27 1QFY27 Revenue (LKR Mn) I
Slide 23: Spice Exports – Performance Highlights
Spice Exports – Performance Highlights Business Highlights 1,713 USD 5.4 Mn The spice export business recorded a revenue growth of 11.5% QoQ in 1QFY27 to reach LKR 1.7 Bn, mainly driven by higher demand for cinnamon and coconut-based products. 1,536 Sales volume grew by 19.5% QoQ and largest contrib
Slide 24: Agribusiness
Agribusiness
Slide 25: Watawala Plantations: palm oil and dairy farming
Watawala Plantations PLC primarily engages in palm oil and dairy farming Palm Oil Revenue Split 1QFY27 A land extent of ~3,400 Ha under palm oil cultivation Inter Co. / Other, 0% Diary, 9% The first in South Asia to receive RSPO certification for sustainable oil palm plantation Positioning – largest
Slide 26: Agribusiness – Highlights
Agribusiness – Highlights Sector Highlights 2,698 2,809 2,492 The Agribusiness sector reported revenue of LKR 2.8 Bn in 1QFY27, reflecting a 12.7% YoY improvement, driven by the 2,078 2,175 performance of the palm oil business. 1,329 1,326 1,216 However, this improvement was partially offset by the
Slide 27: Palm Oil – Performance Highlights
Palm Oil – Performance Highlights Business Highlights 2,398 2,550 2,213 The Palm Oil segment recorded 15.2% YoY improvement in revenue in 1QFY27, driven by volume growth and favorable pricing during 1,813 1,930 the period. 1,385 1,231 830 1,382 548 1QFY26 2QFY26 3QFY26 4QFY26 1QFY27 EBIT (LKR Mn) Re
Slide 28: Dairy – Performance Highlights
Dairy – Performance Highlights Business Highlights 279 300 265 259 245 The dairy business recorded a 7.1% YoY contraction in revenue in 1QFY27, despite the increase in the milk selling price. This underperformance was mainly due to lower milk sales volumes and higher input costs (15) (40) (63) (56)
Slide 29: Q&A
Q&A
Slide 30: Appendix
Appendix
Slide 31: Key ratios – 1QFY27
Key ratios – 1QFY27 INVESTOR RATIOS PROFITABILITY RATIOS 1QFY27 1QFY26 1QFY27 1QFY26 LKR 1.55 LKR 1.64 28.1% 31.8% EPS TTM EPS TTM 15.52% 16.11% GP Margin GP Margin ROE ROE 13.2% 16.6% 20.11 15.78 EBIT Margin EBIT Margin PER TTM PER TTM 9.87 10.06 NAV NAV 7.6% 8.4% 3.15 2.58 PAT Margin PAT Margin PB
Slide 32: Sunshine Pharmaceuticals – Market Dynamics
Sunshine Pharmaceuticals – Market Dynamics During 1Q IQVIA, the market experienced a growth of 9.3% (1Q 2026 YoY %) 16.9% 15.6% 12.0% 11.6% 11.5% 10.2% 10.2% 10.1% 10.1% 9.3% 8.7% 8.9% 7.6% 8.2% 6.7% 4.8% 3.8% 3.1% 2.2% 1.3% 0.0% 0.0% -5.3% -7.3% 1QFY26 2QFY26 3QFY26 4QFY26 1QFY27 RD Value Growth Yo
Slide 33: Sunshine Medical Devices – Market Dynamics
Sunshine Medical Devices – Market Dynamics 100% 89% 88% 88% 86% 90% 86% 81% 85% 81% 84% 84% 82% 81% 77% 79% 79% 79% 77% 77% 76% 73% 75% 70% 2QFY25 3QFY25 4QFY25 1QFY26 2QFY26 3QFY26 4QFY26 1QFY27 Hospital Occupancy Lab Tests Operation Theaters Source – Management Information
Slide 34: Brand Value Market Share (%) – Tea
Brand Value Market Share (%) – Tea 100.0 90.0 23 26 26 28 28 27 27 27 28 28 27 27 29 29 28 28 29 28 29 29 28 28 29 27 28 28 32 30 29 31 29 80.0 8 70.0 9 9 6 6 6 5 5 5 5 5 5 5 5 5 5 6 6 6 5 8 7 7 6 5 4 5 6 6 4 6 60.0 50.0 46 45 45 47 47 48 48 49 49 49 48 48 48 48 50 48 47 48 48 48 50 40.0 45 46 44 45
Slide 35: Brand Value Market Share (%) – Confectionary
Brand Value Market Share (%) – Confectionary 100.0 90.0 23 23 23 23 22 21.6 21 21.3 24 24 24 25 25 25 26 25 24 24 80.0 70.0 14.0 14.9 14.9 15 14.5 17.7 16.3 15.4 14.7 14.4 14.5 15.1 14.2 13.0 13.3 13.7 13.0 17.6 60.0 50.0 36.4 36.2 36.4 37.2 38.1 37.5 38.3 38 34.9 35.1 36.7 35.6 37.2 37.1 35.6 36.4
Slide 36: Price Index – Tea and Confectionary
Price Index – Tea and Confectionary Confectionery Price Index 150 Tea Price Index 147 230 145 143 143 217 217 217 217 217 217 142 210 140 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 193 193 193 135 133 190 131 130 172 172 172 172 172 170 166 125 163 163 164 16
Slide 37: Agribusiness – Price Movement
Agribusiness – Price Movement Settlement Price (RM) WDL's Avg Milk Price (LKR) 5,000 260 4,819 254 255 4,800 250 4,600 4,497 245 MALAYSIAN RINGGITS – RM 4,400 240 235 4,200 230 229 4,000 225 220 3,800 215 3,600 210 3,400 205 December-24 March-25 June-25 September-25 December-25 March-26 June-26 Sour
Slide 38: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements that are based on management’s current expectations and assumptions. Forward-looking statements include predictions of future results or activities and may contain the words “expects,” “believes,” “should,” “will,” “ant
Slide 39: Thank you!
Thank you! For more information, Please visit our Investor Relations page https://www.sunshineholdings.lk/investor-relations/